Concepedia

Xin Du

XD

11

Publications

729

Citations

11

H-Index

2011

Active since

Affiliations

China Medical University(Current)

Tianjin Medical University Cancer Institute and Hospital

First Hospital of China Medical University

Xin Du is an author at China Medical University specializing in medicine, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

2011–2021

11

Publications

11

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity

Zhiqiang Ning, Zhibin Li, Michael Newman et al. · Cancer Chemotherapy and Pharmacology · 2011 · 284 citations

, , +9

FOXF2 suppresses the FOXC2-mediated epithelial–mesenchymal transition and multidrug resistance of basal-like breast cancer

Jun Cai, Ai-Xian Tian, Qing-Shan Wang et al. · Cancer Letters · 2015 · 118 citations · Full text

ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway

Xiaoqing Li, Xin Du, Dong-Mei Li et al. · Cancer Research · 2015 · 101 citations

Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway

Fada Xia, Yong Chen, Bo Jiang et al. · Cellular Physiology and Biochemistry · 2018 · 69 citations · Full text

HYOU1 facilitates proliferation, invasion and glycolysis of papillary thyroid cancer via stabilizing LDHB mRNA

Jia‐Mei Wang, Jingyi Jiang, Dalin Zhang et al. · Journal of Cellular and Molecular Medicine · 2021 · 40 citations · Full text

Rows per page

1–5 of 11